Minimally Invasive Ridge Splitting Versus the Conventional Open Flap Technique

Launched by THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH · Mar 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different techniques for placing dental implants in patients who have experienced bone loss in their jaws. The researchers want to find out if a newer method called "minimally invasive ridge splitting" leads to better implant stability and less bone loss compared to the traditional "open flap technique," which involves making a larger cut in the gums. Participants will be divided into two groups: one will receive the new technique, and the other will undergo the conventional method. By comparing the results, the goal is to see which technique works better for patients.

To be eligible for this trial, participants should have a specific type of bone loss in the back of their lower jaw and meet certain criteria, such as having enough bone height and width for implant placement. They should also be in good overall health and committed to attending follow-up appointments. However, individuals with certain health conditions, like uncontrolled diabetes or those currently on medications that could slow healing, may not be eligible. If you decide to participate, you can expect to receive either of the two techniques and be monitored for how well the implants succeed and how much bone loss occurs over time.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • 1. Patients with atrophic posterior mandibular ridge with edentulous area 30-40 mm, minimum width 3-4 mm, and adequate height indicated for implant placement \>9 mm.
• • 2. Patient with Bone density D2 and D3.
• • 3. Good general systemic condition.
• • 4. Committed patient to attend follow up appointment.
• Exclusion criteria:
• • 1. Patients with systemic diseases that may affect the healing process of hard or soft tissues (e.g., uncontrolled diabetes mellitus).
• • 2. Patient on medication that could hinder the normal healing process (e.g., steroids, immunosuppressant)
• • 3. Patients with intra-bony lesions or infections.
• • 4. Patient with bad habits (e.g. alcohol or Substance abuse).
• • 5. Patient who received head and neck radiotherapy or chemotherapy in the last 10 years.